Lomé, August 13, 2026 — The West African region stands at a pivotal juncture: either continue importing medicines in bulk or build a homegrown pharmaceutical industry. This stark reality brought together medical and academic leaders across the subregion on August 12 at the Agora Senghor in Lomé, laying the groundwork for a sweeping overhaul of West Africa’s health strategy.
During the 21st edition of the Federation of West African Pharmacy Students (FESPAO) Scientific and Cultural Conference, the region’s future medical elite made a bold demand—not for increased funding, but for a fundamental shift in policy. The outdated model of pharmacy as mere distribution outlets is being abandoned in favor of industrialization, genomic research, and scientific validation of traditional knowledge.
Local production: a national security imperative
The global pandemic and recent supply chain disruptions have exposed a dangerous vulnerability: reliance on foreign pharmaceutical imports is no longer just an economic issue—it is a national security flaw. This was the core message delivered at the summit.
The Togolese government, led by President Faure Essozimna Gnassingbé, has set a new national priority: transforming pharmaceutical innovation and local production into the region’s shield against future health crises. Supporting this vision, Professor Gado Tchangbédji, Minister of Higher Education and Research, outlined a bold plan to invest in scientific cooperation and applied research.
Genomic epidemiology and indigenous knowledge take center stage
Yet local production alone is insufficient if it merely replicates foreign patents. True sovereignty requires treatments tailored to African populations. By prioritizing “genomic epidemiology,” the Lomé conference highlighted an urgent scientific need: developing therapies aligned with the genetic makeup of African people—populations long underrepresented in global clinical trials.
Alongside cutting-edge science, there is a cultural resurgence. Experts are pushing for the industrial-scale validation of traditional medicine. No longer should herbal remedies remain informal practices; instead, they must undergo rigorous clinical trials to unlock and patent 100% African-derived active compounds.
Pharmacists of the future: from dispensers to innovators
This industrial and scientific ambition faces a critical challenge: human capital. As the sector evolves, so must academic training. Professor Tchin Darré, Minister of Health and Dean of the Faculty of Health Sciences at the University of Lomé, emphasized the need to reform pharmacy curricula. Tomorrow’s West African pharmacists cannot be trained merely to dispense medication behind a counter—they must become researchers, industrial leaders, and validators of indigenous knowledge systems.
As discussions continue in Lomé, the goal of these 21st FESPAO Assises is clear: turn academic debates into enforceable public policy. The aim is to end the region’s dependence on distant manufacturing plants and ensure universal healthcare access is no longer contingent on factories thousands of miles away.
The stakes are life-and-death. Without a robust local pharmaceutical industry and research anchored in African realities, West Africa will remain beholden to external solutions. When the next pandemic strikes, that dependence could cost lives. True health sovereignty will be measured by the ability of states to move from resolutions to action—ensuring every African patient receives care designed, validated, and produced on the continent.